Single-Center Experience Using Selexipag in a Pediatric Population.
about
Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension.Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?
P2860
Single-Center Experience Using Selexipag in a Pediatric Population.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Single-Center Experience Using Selexipag in a Pediatric Population.
@en
Single-Center Experience Using Selexipag in a Pediatric Population.
@nl
type
label
Single-Center Experience Using Selexipag in a Pediatric Population.
@en
Single-Center Experience Using Selexipag in a Pediatric Population.
@nl
prefLabel
Single-Center Experience Using Selexipag in a Pediatric Population.
@en
Single-Center Experience Using Selexipag in a Pediatric Population.
@nl
P2093
P2860
P1433
P1476
Single-Center Experience Using Selexipag in a Pediatric Population.
@en
P2093
Diana E Drogalis-Kim
Gary Satou
Juan Alejos
Roberto Gallotti
P2860
P2888
P304
P356
10.1007/S00246-017-1677-7
P577
2017-07-13T00:00:00Z